Tanya M Dwarte

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants

A. Spigelman, A. Johns, M. Delatycki, 2021, Hereditary cancer in clinical practice.

Enhancing the anti-angiogenic action of histone deacetylase inhibitors

M. Haber, M. Norris, G. Marshall, 2007, Molecular Cancer.

TUBB 3 / b III-Tubulin Acts through the PTEN / AKT Signaling Axis to Promote Tumorigenesis and Anoikis Resistance in Non – Small Cell Lung Cancer

M. Kavallaris, J. McCarroll, Amelia L. Parker, 2015 .

TUBB3/βIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer.

M. Kavallaris, J. McCarroll, Amelia L. Parker, 2015, Cancer research.

Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers.

D. Goldstein, C. Boyer, S. Sagnella, 2013, Molecular pharmaceutics.

βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells

W. S. Teo, M. Kavallaris, J. McCarroll, 2022, Cancer medicine.

Direct measurement of the rate of glutathione synthesis in 1-chloro-2,4-dinitrobenzene treated human erythrocytes.

A. Luty, J. Raftos, Tanya M Dwarte, 2006, Redox report : communications in free radical research.